SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

A court denied AppLovins request to temporarily block Unitys Ad Quality SDK, intensifying concern that Unity could gain a competitive edge using data from AppLovins ad auctions; analyst caution about growth and Pixel adoption added pressure. Traders are divided between viewing the selloff as excessive given AppLovins profitability and growth, and seeing the weak price action as a warning of further downside.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A weaker-than-expected jobs report eased rate-hike concerns and Treasury yields, prompting a relief bounce in rate-sensitive small caps. Traders remain divided on whether the rebound can hold, with many noting IWMs recent underperformance and focus on support near its 200-day moving average.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Apples Safari/WebKit blocking of a Trade Desk ad-serving domain has intensified concern about potential ad delivery and tracking impacts, though traders debate whether it is an unintended technical issue or a material business threat. The discussion is compounded by TTDs steep, prolonged decline, slowing growth, competition from Amazon and Google, and frustration with managements lack of response; some investors see an oversold opportunity while others expect further losses.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Toshibas reported plan to double hard-drive capacity for AI data centers has sparked a sharp selloff in Western Digital and Seagate on concerns that added supply could weaken pricing power. Traders are divided between seeing a longer-term competitive threat and calling the reaction overdone because the expansion is years away and AI-driven storage demand remains strong; many are buying the dip.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Attention centers on YARTEMLEAs stronger-than-expected launch and Q2 sales, which brought Omeros to reported operating breakeven and helped prompt a Cantor upgrade; traders are watching whether reimbursement tailwinds support continued uptake. Bulls see scope for a commercial re-rating, while skeptics point to the EMAs negative European opinion and the stocks volatility.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas shares remain under pressure after earnings and reduced guidance, with traders pointing to weakness in Germany and near-term investment spending as concerns. Bulls argue that improving profitability and growth opportunities from Apple financing and other partnerships are being overlooked, while bears remain focused on the weak price action and execution risks.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives proposed Supply Squeeze governance update is driving bullish discussion, with traders focused on the possibility that it could double INJs deflation rate through increased token burns; the proposal has not been confirmed as passed. The optimism is reinforced by claims of strong development and revenue activity, but it competes with skepticism about INJs prolonged price decline and complaints about repetitive promotion of ecosystem memecoins.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias Teva patent-litigation settlement, which delays generic voclosporin entry and affirms the patents under the settlement terms, is driving attention. Traders largely view it as a positive precedent that could support further settlements, while others are waiting for remaining cases to resolve and caution that buyout talk is speculative.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A high-volume breakout through a key resistance level, without a confirmed company announcement, has fueled speculation about institutional buying and short covering; some traders expect a squeeze, while others caution that the rally lacks a clear new catalyst. Bullish discussion also points to Anktivas commercial growth and the pending FDA review of a bladder-cancer label expansion, though approval and further price gains remain uncertain.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is drawing attention as crude prices pull back amid the U.S. ruling out a diesel export ban and the G7 coordinating an emergency release of oil and petroleum products, fueling supply-relief concerns. Traders are divided between expecting a rebound in oil and watching for further declines, with debate over crudes support and UCOs leveraged volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

CYBS CyberSource Corporation